Quest Diagnostics (DGX) said Wednesday that it now expects that worse-than-expected weather to trim Q1 revenue by $25 million and EPS by $0.10.
The medical testing services company also said it continues to expect 2025 adjusted diluted earnings of $9.55 to $9.80 per share on net revenue of $10.70 billion to $10.85 billion.
Analysts polled by FactSet expect non-GAAP EPS of $9.71 on sales of $10.79 billion.
Shares of the company were down more than 1% in recent premarket activity on Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.